Generated: December 17, 2017
DrugPatentWatch Database Preview
Details for Patent: 7,465,462
« Back to Dashboard
Which drugs does patent 7,465,462 protect, and when does it expire?
Summary for Patent: 7,465,462
|Title:||Multiparticulate controlled release selective serotonin reuptake inhibitor formulations|
|Abstract:||A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a pharmaceutically acceptable salt thereof, which are coated with a rate-controlling polymer that allows controlled release of the SSRI over a period of not less than about 12 hours after oral administration. The rate controlling polymer includes a film-forming water-insoluble polymer, or a mixture of a film-forming water-insoluble polymer and a film-forming water-soluble polymer.|
|Inventor(s):|| Jeary; Theresa Ann (Roscommon, IE), Morrissey; Catherine Ann (County Westmeath, IE), Stark; Paul (County Westmeath, IE) |
|Assignee:|| Elan Pharma International Limited (Monksland Athlone County Westmeath, IL) |
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Dosage form; Device; Use; |
Foreign Priority and PCT Information for Patent: 7,465,462
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|Ireland||990406||May 20, 1999|
|PCT Filed||May 10, 2000||PCT Application Number:||PCT/IE00/00060|
|PCT Publication Date:||November 30, 2000||PCT Publication Number:||
International Patent Family for Patent: 7,465,462
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.